NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Let me respond in kind. You are mistaken. Instead, they can share topline data without unblinding the trial. For instance, in the Mystic trial, AZN plans on releasing topline results for PFS this year and OS next year. They will not unblind the trial in the meantime because they need OS blinded results to reach their event point. You are assuming because NWBO won't unblind that they can't share topline data, this is incorrect. A trial can remain blinded after sharing topline results in order to reach the secondary endpoints.